Inspire Investing, LLC Myriad Genetics Inc Transaction History

Inspire Investing, LLC

  • $858 Million
  • Q4 2024

A detailed history of Inspire Investing, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Inspire Investing, LLC holds 31,373 shares of MYGN stock, worth $385,260. This represents 0.05% of its overall portfolio holdings.

Number of Shares
31,373
Previous 16,967 84.91%
Holding current value
$385,260
Previous $464,000 7.33%
% of portfolio
0.05%
Previous 0.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
BUY
$13.17 - $27.03 $189,727 - $389,394
14,406 Added 84.91%
31,373 $430,000
Q3 2024

Oct 10, 2024
BUY
$23.97 - $28.6 $60,835 - $72,586
2,538 Added 17.59%
16,967 $464,000
Q2 2024

Aug 12, 2024
SELL
$17.98 - $25.47 $40,023 - $56,696
-2,226 Reduced 13.37%
14,429 $352,000
Q1 2024

May 07, 2024
SELL
$17.59 - $23.59 $62,602 - $83,956
-3,559 Reduced 17.61%
16,655 $355,000
Q4 2023

Feb 12, 2024
BUY
$13.91 - $21.32 $16,858 - $25,839
1,212 Added 6.38%
20,214 $386,000
Q3 2023

Oct 26, 2023
BUY
$15.99 - $23.22 $88,024 - $127,826
5,505 Added 40.79%
19,002 $304,000
Q2 2023

Jul 31, 2023
BUY
$17.56 - $23.76 $30,045 - $40,653
1,711 Added 14.52%
13,497 $312,000
Q1 2023

Apr 24, 2023
SELL
$15.26 - $23.75 $76,177 - $118,560
-4,992 Reduced 29.75%
11,786 $273,000
Q4 2022

Jan 26, 2023
BUY
$14.51 - $20.99 $89,221 - $129,067
6,149 Added 57.85%
16,778 $0
Q3 2022

Nov 07, 2022
SELL
$18.21 - $27.88 $18,027 - $27,601
-990 Reduced 8.52%
10,629 $203,000
Q2 2022

Aug 10, 2022
BUY
$16.45 - $25.88 $36,864 - $57,997
2,241 Added 23.9%
11,619 $211,000
Q1 2022

Apr 21, 2022
BUY
$22.67 - $28.01 $11,403 - $14,089
503 Added 5.67%
9,378 $236,000
Q4 2021

Feb 14, 2022
BUY
$24.13 - $32.63 $214,153 - $289,591
8,875 New
8,875 $245,000
Q4 2021

Feb 03, 2022
SELL
$24.13 - $32.63 $168,813 - $228,279
-6,996 Closed
0 $0
Q3 2021

Nov 09, 2021
SELL
$29.97 - $36.66 $35,604 - $43,552
-1,188 Reduced 14.52%
6,996 $226,000
Q2 2021

Aug 10, 2021
BUY
$25.39 - $32.61 $6,296 - $8,087
248 Added 3.13%
8,184 $250,000
Q1 2021

Apr 30, 2021
SELL
$19.92 - $31.6 $81,512 - $129,307
-4,092 Reduced 34.02%
7,936 $242,000
Q4 2020

Feb 12, 2021
SELL
$12.16 - $19.77 $7,393 - $12,020
-608 Reduced 4.81%
12,028 $238,000
Q3 2020

Nov 16, 2020
BUY
$11.25 - $14.75 $142,155 - $186,381
12,636 New
12,636 $165,000
Q1 2018

Apr 13, 2018
SELL
$28.83 - $41.01 $46,618 - $66,313
-1,617 Closed
0 $0
Q4 2017

Feb 15, 2018
BUY
$28.45 - $37.14 $46,003 - $60,055
1,617
1,617 $56,000

Others Institutions Holding MYGN

# of Institutions
250
Shares Held
90.6M
Call Options Held
100K
Put Options Held
34K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $990M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email